GUADAGNI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.958
AS - Asia 5.002
EU - Europa 814
SA - Sud America 515
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 99
OC - Oceania 17
Totale 14.586
Nazione #
US - Stati Uniti d'America 6.904
TR - Turchia 2.401
CN - Cina 1.220
CA - Canada 1.004
SG - Singapore 922
BR - Brasile 432
IT - Italia 269
EU - Europa 177
VN - Vietnam 149
IE - Irlanda 99
IN - India 93
DE - Germania 77
GB - Regno Unito 64
HK - Hong Kong 45
FI - Finlandia 44
ZA - Sudafrica 36
RU - Federazione Russa 33
MX - Messico 32
PL - Polonia 31
AR - Argentina 30
BD - Bangladesh 30
ES - Italia 30
ID - Indonesia 29
SC - Seychelles 29
FR - Francia 28
JP - Giappone 28
UA - Ucraina 26
NL - Olanda 21
RO - Romania 17
SE - Svezia 16
EC - Ecuador 14
IQ - Iraq 14
LT - Lituania 14
AU - Australia 13
SA - Arabia Saudita 11
CL - Cile 9
PK - Pakistan 9
PY - Paraguay 9
KR - Corea 8
MA - Marocco 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 5
KE - Kenya 5
BB - Barbados 4
CH - Svizzera 4
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
PE - Perù 4
PH - Filippine 4
SN - Senegal 4
TH - Thailandia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BE - Belgio 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 14.574
Città #
Kocaeli 2.103
San Mateo 1.619
Dallas 1.188
Toronto 960
Wilmington 464
Houston 425
Santa Clara 369
Beijing 347
Lawrence 322
Princeton 322
Singapore 293
Ashburn 233
Chandler 210
Seattle 132
Fairfield 129
Los Angeles 109
Woodbridge 101
Shanghai 99
Guangzhou 66
Cambridge 55
Ho Chi Minh City 55
Rome 46
São Paulo 43
Brooklyn 41
Hong Kong 40
Dublin 36
Hanoi 36
Helsinki 33
Shenzhen 32
Redwood City 31
New York 28
Warsaw 27
The Dalles 26
Chicago 24
Tokyo 24
Johannesburg 22
Columbus 21
Boston 17
Munich 17
Saint Petersburg 17
Wuhan 16
London 15
Quanzhou 15
Redmond 15
Mexico City 14
Milan 14
Montreal 14
Rio de Janeiro 14
Chennai 13
Council Bluffs 13
Jiaxing 13
Rui'an 12
Washington 12
Xi'an 12
Nanjing 11
Pune 11
Wuxi 11
Ankara 10
Atlanta 10
Kyiv 10
Mumbai 10
Phoenix 10
San Francisco 10
Bandung 9
Belo Horizonte 9
Pesaro 9
Stockholm 9
Turku 9
Amsterdam 8
Bari 8
Dongyang 8
Frankfurt am Main 8
Jinhua 8
Taizhou 8
Curitiba 7
Nantong 7
Philadelphia 7
Vicenza 7
Xuzhou 7
Zhengzhou 7
Asunción 6
Campinas 6
Caxias do Sul 6
Changsha 6
Charlotte 6
Denver 6
Hefei 6
Jakarta 6
Rockville 6
Seoul 6
Thái Nguyên 6
Dhaka 5
Guayaquil 5
Haiphong 5
Jinan 5
Porto Alegre 5
Qingdao 5
Riyadh 5
Aarhus 4
Brasília 4
Totale 10.691
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 118
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 117
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 110
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 105
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 96
Activation of blood coagulation in breast cancer - relationship to clinical outcome 93
Aging: an important risk factor in chemotherapy-associated vascular diseases 87
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 85
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 85
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 83
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 83
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 80
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 80
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 79
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 78
A Simple and Effective Method to Analyze Membrane Proteins by SDS-PAGE and MALDI Mass Spectrometry 78
A NOVEL NONSENSE MUTATION IN KRAS GENE 77
An AT-Rich Region in the APC Gene May Cause Misinterpretation of Familial Adenomatous Polyposis Molecular Screening 77
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 76
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 75
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 74
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 72
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 71
Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection 71
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 71
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 67
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 66
"Proteomineering" or not? The debate on biomarker discovery in sera continues 64
Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression 64
Age-related reduction of cerebral ischemic preconditioning: myth or reality? 62
MAINTENANCE OF EXPRESSION OF TUMOR-ANTIGENS IN 3-DIMENSIONAL INVITRO HUMAN TUMOR GEL-SUPPORTED HISTOCULTURE 61
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 61
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 60
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 59
“Personal and sensitive data in the e-health-IoT universe” 59
Tumor markers as targets for selective diagnostic and therapeutic procedures 58
VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients 58
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 58
Protective Effect of Antioxidants in Nitric Oxide/COX-2 Interaction during Inflammatory Pain: The Role of Nitration 58
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 57
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 57
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 57
Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing 57
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 56
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 56
Role of interleukin-6 in the diagnosis of acute aortic dissection 56
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 56
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 56
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 55
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 55
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 55
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 55
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 55
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 55
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 55
In vitro interactions between blood platelets and human colorectal tumor cells 54
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 54
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 54
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 54
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 54
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 54
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 53
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 53
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 53
Sentinel lymphadenectomy in cutaneous melanoma 53
Machine learning approach to predict medication overuse in migraine patients 53
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 53
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 53
Is CEA serum measurement useful in monitoring breast cancer patients? 52
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 52
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 52
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 52
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 52
Artificial intelligence for cancer-associated thrombosis risk assessment 52
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 52
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 51
SERUM LEPTIN LEVELS IN COLORECTAL CANCER PATIENTS 51
Biomarkers of platelet activation in acute coronary syndromes 51
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients 51
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 51
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 51
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus 51
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 51
Plasma Plasminogen Activator Inhibitor-1 (PAI-1) Levels in Breast Cancer - Relationship with Clinical Outcome 51
Metabolic Syndrome (MetS) in Metastatic (m) Colorectal Cancer (CRC) Patients (pts) Might Delay the Onset of Cachexia 50
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 50
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 50
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 50
BRCA1 and BRCA2 mutations in central and southern Italian patients 50
The insulin-glucose axis in breast cancer - relationship to clinical outcome 49
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 49
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 49
CA-72-4 MEASUREMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72) AS A SERUM MARKER IN THE MANAGEMENT OF GASTRIC-CARCINOMA 49
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B) 49
Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group 49
Enhanced expression of LINE-1 encoded ORF2 protein in early stages of colon and prostate transformation 49
Breast Cancer Prognosis Using a Machine Learning Approach 49
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 48
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients 48
Evaluation of the clinical impact of serum tumor markers in gastric cancer. A prospective longitudinal study 48
Totale 6.173
Categoria #
all - tutte 159.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.904 0 0 0 0 105 148 95 55 99 59 2.113 230
2021/20223.140 19 961 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.898 158 642 144 110 162 499 197 145 325 20 80 416
2025/20262.684 534 751 922 475 2 0 0 0 0 0 0 0
Totale 15.053